Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Autoimmune Disorders

  Free Subscription


Articles published in Ann Neurol

Retrieve available abstracts of 68 articles:
HTML format
Text format



Single Articles


    May 2018
  1. DISANTO G, Zecca C, MacLachlan S, Sacco R, et al
    Prodromal symptoms of multiple sclerosis in primary care.
    Ann Neurol. 2018 May 8. doi: 10.1002/ana.25247.
    PubMed     Text format     Abstract available


    April 2018
  2. TANKOU SK, Regev K, Healy BC, Tjon E, et al
    A probiotic modulates the microbiome and immunity in multiple sclerosis.
    Ann Neurol. 2018 Apr 20. doi: 10.1002/ana.25244.
    PubMed     Text format     Abstract available


  3. VOGRIG A, Brigo F, Valente M, Gigli GL, et al
    Epidemiology of autoimmune versus infectious encephalitis.
    Ann Neurol. 2018 Apr 10. doi: 10.1002/ana.25229.
    PubMed     Text format    


  4. DUBEY D, Pittock SJ, Toledano M, Flanagan EP, et al
    Reply to "Epidemiology of autoimmune versus infectious encephalitis".
    Ann Neurol. 2018 Apr 10. doi: 10.1002/ana.25230.
    PubMed     Text format    


    March 2018
  5. CRAMER SP, Simonsen HJ, Varatharaj A, Galea I, et al
    Permeability of the blood-brain barrier predicts no evidence of disease activity at two years after natalizumab or fingolimod treatment in relapsing-remitting multiple sclerosis.
    Ann Neurol. 2018 Mar 31. doi: 10.1002/ana.25219.
    PubMed     Text format     Abstract available


  6. ANTEL J
    The reality of "ghosts" in authorship of clinical trials in multiple sclerosis.
    Ann Neurol. 2018 Mar 13. doi: 10.1002/ana.25199.
    PubMed     Text format    


  7. COLES A
    Authorship of phase 3 trials in multiple sclerosis.
    Ann Neurol. 2018 Mar 8. doi: 10.1002/ana.25203.
    PubMed     Text format    


  8. MAGLIOZZI R, Howell OW, Nicholas R, Cruciani C, et al
    Inflammatory intrathecal profiles and cortical damage in multiple sclerosis.
    Ann Neurol. 2018 Mar 8. doi: 10.1002/ana.25197.
    PubMed     Text format     Abstract available


    January 2018
  9. ESHAGHI A, Prados F, Brownlee W, Altmann DR, et al
    Deep grey matter volume loss drives disability worsening in multiple sclerosis.
    Ann Neurol. 2018 Jan 13. doi: 10.1002/ana.25145.
    PubMed     Text format     Abstract available


  10. DUBEY D, Pittock SJ, Kelly CR, McKeon A, et al
    Autoimmune Encephalitis Epidemiology and a comparison to Infectious Encephalitis.
    Ann Neurol. 2018 Jan 2. doi: 10.1002/ana.25131.
    PubMed     Text format     Abstract available


    December 2017
  11. GILES DA, Washnock-Schmid JM, Duncker PC, Dahlawi S, et al
    Myeloid cell plasticity in the evolution of central nervous system autoimmunity.
    Ann Neurol. 2017 Dec 28. doi: 10.1002/ana.25128.
    PubMed     Text format     Abstract available


  12. GREENFIELD AL, Hauser SL
    B Cell Therapy for Multiple Sclerosis: Entering an Era.
    Ann Neurol. 2017 Dec 15. doi: 10.1002/ana.25119.
    PubMed     Text format     Abstract available


  13. PATTERSON KR, Dalmau J, Lancaster E
    Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia.
    Ann Neurol. 2017 Dec 15. doi: 10.1002/ana.25120.
    PubMed     Text format     Abstract available


    November 2017
  14. KANAI T, Uzawa A, Sato Y, Suzuki S, et al
    A clinical predictive score for postoperative myasthenic crisis.
    Ann Neurol. 2017;82:841-849.
    PubMed     Text format     Abstract available


    October 2017
  15. BARBOUR C, Kosa P, Komori M, Tanigawa M, et al
    Molecular-based diagnosis of Multiple Sclerosis and its progressive stage.
    Ann Neurol. 2017 Oct 23. doi: 10.1002/ana.25083.
    PubMed     Text format     Abstract available


  16. AZODI S, Nair G, Enose-Akahata Y, Charlip E, et al
    Imaging Spinal Cord Atrophy in Progressive Myelopathies: HTLV-I Associated Neurologic Disease (HAM/TSP) and Multiple Sclerosis (MS).
    Ann Neurol. 2017 Oct 10. doi: 10.1002/ana.25072.
    PubMed     Text format     Abstract available


  17. JENDE JME, Hauck GH, Diem R, Weiler M, et al
    Peripheral nerve involvement in multiple sclerosis Demonstration by magnetic resonance neurography.
    Ann Neurol. 2017 Oct 10. doi: 10.1002/ana.25068.
    PubMed     Text format     Abstract available


  18. MAINERO C, Louapre C
    Unravelling cortical pathology in multiple sclerosis using the T1-/T2-weighted ratio?
    Ann Neurol. 2017 Oct 4. doi: 10.1002/ana.25063.
    PubMed     Text format    


  19. WIJNANDS JMA, Tremlett H
    Concussion may not cause multiple sclerosis.
    Ann Neurol. 2017 Oct 4. doi: 10.1002/ana.25061.
    PubMed     Text format    


  20. MONTGOMERY S, Hiyoshi A, Burkill S, Alfredsson L, et al
    Reply to: Concussion may not cause multiple sclerosis.
    Ann Neurol. 2017 Oct 4. doi: 10.1002/ana.25062.
    PubMed     Text format    


    September 2017
  21. FITZGERALD KC, Munger KL, Ascherio A
    Reply to "Stratified analyses are necessary to verify the influence of salt intake in multiple sclerosis".
    Ann Neurol. 2017 Sep 29. doi: 10.1002/ana.25055.
    PubMed     Text format    


  22. ZAHEDNASAB H, Harirchian MH, Karampoor S, Keyvani H, et al
    MMP-9 as a biomarker of PML development in MS patients receiving Natalizumab.
    Ann Neurol. 2017 Sep 4. doi: 10.1002/ana.25037.
    PubMed     Text format    


  23. FISSOLO N, Pignolet B, Brassat D, Comabella M, et al
    Reply: MMP-9 as a biomarker of PML development in MS patients receiving Natalizumab.
    Ann Neurol. 2017 Sep 4. doi: 10.1002/ana.25039.
    PubMed     Text format    


  24. MONTGOMERY S, Hiyoshi A, Burkill S, Alfredsson L, et al
    Concussion in adolescence and risk of multiple sclerosis.
    Ann Neurol. 2017 Sep 4. doi: 10.1002/ana.25036.
    PubMed     Text format     Abstract available


    August 2017
  25. NAKAMURA K, Chen JT, Ontaneda D, Fox RJ, et al
    T1-/T2-weighted ratio differs in demyelinated cortex of multiple sclerosis.
    Ann Neurol. 2017 Aug 18. doi: 10.1002/ana.25019.
    PubMed     Text format     Abstract available


  26. RIGHART R, Biberacher V, Jonkman LE, Klaver R, et al
    Cortical pathology in MS detected by the T1/T2-weighted ratio from routine MRI.
    Ann Neurol. 2017 Aug 18. doi: 10.1002/ana.25020.
    PubMed     Text format     Abstract available


  27. DALAKAS MC, Rakocevic G, Dambrosia JM, Alexopoulos H, et al
    A double-blind, placebo-controlled study of rituximab in patients with stiff person syndrome.
    Ann Neurol. 2017;82:271-277.
    PubMed     Text format     Abstract available


    July 2017
  28. YATES RL, Esiri MM, Palace J, Jacobs B, et al
    Fibrin(ogen) and neurodegeneration in the progressive multiple sclerosis cortex.
    Ann Neurol. 2017 Jul 18. doi: 10.1002/ana.24997.
    PubMed     Text format     Abstract available


  29. FISSOLO N, Pignolet B, Matute-Blanch C, Trivino JC, et al
    MMP9 is decreased in natalizumab-treated MS patients at risk for PML.
    Ann Neurol. 2017 Jul 6. doi: 10.1002/ana.24987.
    PubMed     Text format     Abstract available


    May 2017
  30. FITZGERALD KC, Munger KL, Hartung HP, Freedman MS, et al
    Sodium intake and multiple sclerosis activity and progression in BENEFIT.
    Ann Neurol. 2017 May 26. doi: 10.1002/ana.24965.
    PubMed     Text format     Abstract available


  31. DISANTO G, Barro C, Benkert P, Naegelin Y, et al
    Serum neurofilament light: A biomarker of neuronal damage in multiple sclerosis.
    Ann Neurol. 2017 May 16. doi: 10.1002/ana.24954.
    PubMed     Text format     Abstract available


  32. CUI QL, Khan D, Rone M, Rao V, et al
    Sublethal oligodendrocyte injury: A reversible condition in multiple sclerosis?
    Ann Neurol. 2017 May 3. doi: 10.1002/ana.24944.
    PubMed     Text format     Abstract available


  33. IAFFALDANO P, Simone M, Lucisano G, Ghezzi A, et al
    Prognostic indicators in pediatric clinically isolated syndrome.
    Ann Neurol. 2017;81:729-739.
    PubMed     Text format     Abstract available


    April 2017
  34. ANDRODIAS G, Bernard E, Biotti D, Collongues N, et al
    Multiple sclerosis broke my heart.
    Ann Neurol. 2017 Apr 24. doi: 10.1002/ana.24935.
    PubMed     Text format     Abstract available


  35. SELMAJ I, Cichalewska M, Namiecinska M, Galazka G, et al
    Global Exosome Transcriptome Profiling Reveals Biomarkers for Multiple Sclerosis.
    Ann Neurol. 2017 Apr 15. doi: 10.1002/ana.24931.
    PubMed     Text format     Abstract available


    March 2017
  36. TAWARA N, Yamashita S, Zhang X, Korogi M, et al
    Pathomechanisms of anti-cN1A autoantibodies in sporadic inclusion body myositis.
    Ann Neurol. 2017 Mar 20. doi: 10.1002/ana.24919.
    PubMed     Text format     Abstract available


  37. TREMLETT H, Bauer KC, Appel-Cresswell S, Finlay BB, et al
    The gut microbiome in human neurological disease: A review.
    Ann Neurol. 2017;81:369-382.
    PubMed     Text format     Abstract available


    February 2017
  38. AROUCHE-DELAPERCHE L, Allenbach Y, Amelin D, Preusse C, et al
    Pathogenic role of anti-SRP and anti-HMGCR antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies.
    Ann Neurol. 2017 Feb 22. doi: 10.1002/ana.24902.
    PubMed     Text format     Abstract available


  39. KIM TJ, Lee ST, Moon J, Sunwoo JS, et al
    Anti-LGI1 encephalitis is associated with unique HLA subtypes.
    Ann Neurol. 2017;81:183-192.
    PubMed     Text format     Abstract available


    January 2017
  40. GONZALEZ-BILLAULT C
    The identity of the PCA-2 autoantibody antigen is finally revealed.
    Ann Neurol. 2017 Jan 30. doi: 10.1002/ana.24884.
    PubMed     Text format    


  41. FLANAGAN EP, Hinson SR, Lennon VA, Fang B, et al
    GFAP-IgG as Biomarker of Autoimmune Astrocytopathy: Analysis of 102 Patients.
    Ann Neurol. 2017 Jan 24. doi: 10.1002/ana.24881.
    PubMed     Text format     Abstract available


    December 2016
  42. HERRANZ E, Hooker JM, Izquierdo-Garcia D, Loggia ML, et al
    11 C-PBR28 increase in multiple sclerosis reflects neuroinflammation.
    Ann Neurol. 2016 Dec 29. doi: 10.1002/ana.24865.
    PubMed     Text format    


  43. RAFFEL J, Sridharan S, Nicholas R
    [11 C]PBR-28 PET in multiple sclerosis: Neuroinflammation or otherwise?
    Ann Neurol. 2016 Dec 26. doi: 10.1002/ana.24853.
    PubMed     Text format    


    October 2016
  44. GOBEL K, Kraft P, Pankratz S, Gross CC, et al
    Prothrombin and factor X are elevated in multiple sclerosis patients.
    Ann Neurol. 2016 Oct 24. doi: 10.1002/ana.24807.
    PubMed     Text format     Abstract available


    September 2016
  45. HERRANZ E, Gianni C, Louapre C, Treaba CA, et al
    The neuroinflammatory component of gray matter pathology in multiple sclerosis.
    Ann Neurol. 2016 Sep 30. doi: 10.1002/ana.24791.
    PubMed     Text format     Abstract available


    August 2016
  46. CORTESE M, Riise T, Bjornevik K, Bhan A, et al
    Pre-clinical disease activity in multiple sclerosis- a prospective study on cognitive performance prior to first symptom.
    Ann Neurol. 2016 Aug 23. doi: 10.1002/ana.24769.
    PubMed     Text format     Abstract available


  47. MEYER SAUTEUR PM, Huizinga R, Tio-Gillen AP, Roodbol J, et al
    Mycoplasma pneumoniae triggering the Guillain-Barre syndrome: A case-control study.
    Ann Neurol. 2016 Aug 4. doi: 10.1002/ana.24755.
    PubMed     Text format     Abstract available


    July 2016
  48. CREE B, Gourraud PA, Oksenberg JR, Bevan C, et al
    Long-term evolution of multiple sclerosis disability in the treatment era.
    Ann Neurol. 2016 Jul 27. doi: 10.1002/ana.24747.
    PubMed     Text format     Abstract available


  49. WINDER K, Linker RA, Seifert F, Deutsch M, et al
    Neuroanatomic Correlates of Female Sexual Dysfunction in Multiple Sclerosis.
    Ann Neurol. 2016 Jul 27. doi: 10.1002/ana.24746.
    PubMed     Text format     Abstract available


  50. WHITE MK, Wollebo HS, Beckham JD, Tyler KL, et al
    Zika virus: An emergent neuropathological agent.
    Ann Neurol. 2016 Jul 27. doi: 10.1002/ana.24748.
    PubMed     Text format     Abstract available


    June 2016
  51. GERDES LA, Held K, Beltran E, Berking C, et al
    CTLA-4 as immunological checkpoint in the development of multiple sclerosis.
    Ann Neurol. 2016 Jun 28. doi: 10.1002/ana.24715.
    PubMed     Text format     Abstract available


    May 2016
  52. JOKUBAITIS VG, Spelman T, Kalincik T, Lorscheider J, et al
    Predictors of long-term disability accrual in relapse-onset multiple sclerosis.
    Ann Neurol. 2016 May 4. doi: 10.1002/ana.24682.
    PubMed     Text format     Abstract available


    April 2016
  53. HARSCHNITZ O, van den Berg LH, Johansen LE, Jansen MD, et al
    Autoantibody pathogenicity in a multifocal motor neuropathy iPSC-derived model.
    Ann Neurol. 2016 Apr 30. doi: 10.1002/ana.24680.
    PubMed     Text format     Abstract available


  54. BODINI B, Veronese M, Turkheimer F, Stankoff B, et al
    Benzothiazole and stilbene derivatives as promising PET myelin radiotracers for multiple sclerosis.
    Ann Neurol. 2016 Apr 21. doi: 10.1002/ana.24667.
    PubMed     Text format    


  55. MATIAS-GUIU JA, Cabrera-Martin MN, Oreja-Guevara C, Carreras JL, et al
    PiB and other amyloid-PET tracers for the study of white matter and multiple sclerosis.
    Ann Neurol. 2016 Apr 21. doi: 10.1002/ana.24666.
    PubMed     Text format    


  56. HOKARI M, Yokoseki A, Arakawa M, Saji E, et al
    Clinicopathological features in anterior visual pathway in neuromyelitis optica.
    Ann Neurol. 2016;79:605-24.
    PubMed     Text format     Abstract available


    March 2016
  57. ALPING P, Frisell T, Novakova L, Islam-Jakobsson P, et al
    Rituximab versus fingolimod after natalizumab in multiple sclerosis patients.
    Ann Neurol. 2016 Mar 31. doi: 10.1002/ana.24651.
    PubMed     Text format     Abstract available


  58. LASSMANN H
    Demyelination and Neurodegeneration in Multiple Sclerosis: The Role of Hypoxia.
    Ann Neurol. 2016 Mar 9. doi: 10.1002/ana.24632.
    PubMed     Text format    


  59. JELCIC I, Jelcic I, Kempf C, Largey F, et al
    Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant.
    Ann Neurol. 2016;79:404-18.
    PubMed     Text format     Abstract available


  60. FLANAGAN EP, Kaufmann TJ, Krecke KN, Aksamit AJ, et al
    Discriminating long myelitis of neuromyelitis optica from sarcoidosis.
    Ann Neurol. 2016;79:437-47.
    PubMed     Text format     Abstract available


    February 2016
  61. BODINI B, Veronese M, Garcia-Lorenzo D, Battaglini M, et al
    Dynamic imaging of individual remyelination profiles in multiple sclerosis.
    Ann Neurol. 2016 Feb 18. doi: 10.1002/ana.24620.
    PubMed     Text format     Abstract available


  62. FLANAGAN EP, Cabre P, Weinshenker BG, St Sauver J, et al
    Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum.
    Ann Neurol. 2016 Feb 17. doi: 10.1002/ana.24617.
    PubMed     Text format     Abstract available


  63. WEINSHENKER BG
    What Is the Optimal Sequence of Rescue Treatments for Attacks of Neuromyelitis Optica Spectrum Disorder?
    Ann Neurol. 2016;79:204-5.
    PubMed     Text format    


  64. KLEITER I, Gahlen A, Borisow N, Fischer K, et al
    Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses.
    Ann Neurol. 2016;79:206-16.
    PubMed     Text format     Abstract available


    January 2016
  65. DESAI RA, Davies AL, Tachrount M, Kasti M, et al
    Cause and prevention of demyelination in a model multiple sclerosis lesion.
    Ann Neurol. 2016 Jan 27. doi: 10.1002/ana.24607.
    PubMed     Text format     Abstract available


    November 2015
  66. KANTARCI OH, Lebrun C, Siva A, Keegan MB, et al
    Primary Progressive MS evolving from Radiologically Isolated Syndrome.
    Ann Neurol. 2015 Nov 24. doi: 10.1002/ana.24564.
    PubMed     Text format     Abstract available


  67. XIA Z, White CC, Owen EK, Von Korff A, et al
    GEMS Project: A Platform to Investigate Multiple Sclerosis Risk.
    Ann Neurol. 2015 Nov 19. doi: 10.1002/ana.24560.
    PubMed     Text format     Abstract available


  68. SAIDHA S, Al-Louzi O, Ratchford JN, Bhargava P, et al
    Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study.
    Ann Neurol. 2015;78:801-13.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: